2-deoxyglucose

DRUG2 trials

Sponsors

Rutgers, The State University of New Jersey, G.ST Antivirals GmbH

Conditions

Acute NasopharyngitisProstate Cancer

Phase 1

A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer

TerminatedNCT00633087

Rutgers, The State University of New JerseyProstate Cancer

Start: 2006-11-30End: 2011-03-31Updated: 2023-12-22

Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers

CompletedNCT05314933

G.ST Antivirals GmbHAcute Nasopharyngitis

Start: 2022-03-03End: 2023-09-27Updated: 2023-10-12

Related Papers

Safety, tolerability, and pharmacokinetics of intranasal 2-deoxy-D-glucose in normal healthy volunteers: A randomized, double-blind, placebo-controlled, single and multiple ascending dose phase 1 study

European Journal of Pharmaceutical Sciences2025-03-161 citations